Pfizer meets amyloidosis rival

BridgeBio Wins FDA Approval for ATTR-CM Drug, Launching Competition with Pfizer
BridgeBio secured approval for Attruby Friday, along with the all-important mortality benefit that could give the drug a significant boost in the market against Pfizer’s tafamidis and potentially Alnylam’s Amvuttra.
Pfizer meets amyloidosis rival as BridgeBio wins FDA nod for Attruby
BridgeBio Pharma (BBIO) wins FDA nod Attruby for rare heart disorder, ATTR-CM challenging Pfizer's (PFE) Vyndaqel. Read more here.
BridgeBio Pharma : FDA Approves Heart Disease Drug 'acoramidis'
BridgeBio Pharma Inc. (BBIO) announced that the U.S. Food and Drug Administration approved Attruby or acoramidis, an
BridgeBio Gets US Approval for Heart Drug to Compete with Pfizer
BridgeBio Pharma Inc. gained US approval for a drug to treat a progressive and deadly form of heart disease, paving the way for the biotech company to go head-to-head with Pfizer Inc. in an increasingly competitive market.
BridgeBio announces FDA approved Attruby for ATTR-CM patients
Pharma announced that the U.S. Food and Drug Administration approved Attruby, an orally-administered near-complete stabilizer of
BridgeBio wins FDA approval for heart disease drug
The drug, known scientifically as acoramidis, will be sold by BridgeBio under the brand name Attruby. The FDA cleared Attruby to treat patients with the heart condition known as transthyretin amyloid cardiomyopathy,
pharmaphorum4d
Pfizer, BioNTech submit to FDA for Covid vaccine in under 5s
Pfizer and BioNTech have announced that they have submitted an Emergency Use Authorisation (EUA) to the US Food and Drug Administration (FDA ... or approved monovalent COVID-19 vaccine.
justthenews2d
Operation Warp Speed official questions COVID vaccine purity, worries 'they may ingrate' into DNA
Robert Redfield says he's "proud" of work on President Trump's initiative but believes COVID vaccines should be "critically ...
clinicaladvisor.com1d
How HHS, FDA, and CDC Can Influence US Vaccine Policy
Federal officials have significant authority to influence and alter vaccine policy, which could affect vaccine availability, views about vaccines, and vaccine use in the US.
biopharma-reporter12d
FDA removes clinical hold on Novavax’s COVID-19-influenza combo vaccine
The FDA had put a clinical hold on Novavax’s COVID-19-influenza combo vaccine after an adverse event in a patient. The ...
Trump nominates Marty Makary, who opposed COVID vaccine mandates, to head FDA
President-elect Donald Trump has nominated a critic of COVID-19 health measures to lead the Food and Drug Administration.
MarketWatch12d
Novavax to Move Forward With Covid-19-Flu Vaccine After FDA Lifts Clinical Hold -- Update
Pfizer, which is developing the novel vaccine with BioNTech, has reported mixed results for the combined shot. Meanwhile, Moderna said last week that it plans to file for FDA approval of its ...
The Highland County Press2d
Senator threatens legal action to get COVID-19 vaccine data
U.S. Sen. Ron Johnson has threatened to issue a subpoena when he becomes chairman of the Permanent Subcommittee on Investigations if three federal health agencies continue to withhold data on the ...
STAT12d
Risk of aspiration during surgery added to GLP-1 drug labels
The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...